APRE
Aprea Therapeutics, Inc. Common stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Aprea Therapeutics (APRE) Stock: Buy, Sell, or Hold?
$0.44
0.00 (-0.97%)
▼
5d:
-11.12%
30d:
-24.49%
90d:
-35.26%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (58%)
Quality Score
43/100
Position
OVERSOLD
30-Day Fair Range
$0.48 – $0.60
Position: OVERSOLD
Forward P/E & Valuation
-1.0x
Next 12M consensus est.
Wall Street Target
$3.30
+642.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.43 / $0.53
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: APRE is down 11.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When APRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: APRE is currently trading at $0.44, which is considered oversold relative to its 30-day fair value range of $0.48 to $0.60.
Technical Outlook: Technically, APRE is in a downtrend. The price is currently testing key support at $0.43. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: APRE scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.30 (+642.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APRE is in a downtrend. The price is currently testing key support at $0.43. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: APRE scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.30 (+642.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.48 -
$0.60
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Trading Range & Key Levels
30-Day Trading Range
$0.48 -
$0.60
Current vs Trading Range
OVERSOLD
Support Level
$0.43
Resistance Level
$0.53
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 642.4% below Wall St target ($3.30)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.02
Wall Street Target
$3.30
(+642.4%)
Revenue Growth (YoY)
-98.4%
Share APRE Analysis
Share this live APRE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (APRE)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Sep 26, 2026
Daily AI digest
AI Retail Discussion Summary:
Trader on StockTwits expresses bullish sentiment towards $APRE, adding it to their watchlist
Key Retail Themes:
Bullish sentiment
Watchlist addition
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:07 PM ET
Data refreshes hourly during market hours. Next update: 3:07 PM
Data refreshes hourly during market hours. Next update: 3:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 50 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 37 SELL |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive APRE Research Pages
